arrow
C

Christophe Pomel

jean perrin cancer center
H指数:37
被引数:5,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database

高级别浆液性卵巢癌接受高强度细胞减灭术和化疗:淋巴结受累的预后影响:法国国家ESME-Unicancer数据库分析

2026-03-250
PRE
Surgical Approach and Maintenance Therapy in Advanced Low-Grade Serous Ovarian Cancer: Insights from the French ESME Database

晚期低级别浆液性卵巢癌的手术治疗与维持治疗:来自法国ESME数据库的见解

2025-11-140
PRE
Diagnostic laparoscopy and cytoreduction surgery in ovarian cancer FIGO III–IV: The impact on survival of one-stage versus two-stage sequence

卵巢癌FIGO III–IV期:单阶段与两阶段顺序的腹腔镜诊断与细胞减灭术对生存期的影响

2025-09-010
PRE
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database

无铂间期(PFI)及维持治疗在复发性卵巢癌中的作用:解释生存率的法国真实世界ESME卵巢数据库分析

2025-08-070
PRE
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network

PARP抑制剂在铂敏感复发性卵巢癌中的维持治疗:来自Unicancer网络的现实世界经验

2025-05-110
OA
Advanced High-Grade Serous Ovarian Cancer Treated With Intensive Cytoreductive Surgery And Chemotherapy: Prognostic Impact Of Lymph Node Involvement: Analysis Of The French National ESME-Unicancer Database

高级别浆液性卵巢癌经强化细胞减灭术和化疗治疗:淋巴结受累的预后影响:法国国家ESME-Unicancer数据库分析

2025-02-010
PRE
A Retrospective Multicentre Study To Evaluate The Impact Of Platinum-Free Interval On Progression-Free And Overall Survival In Patients With Recurrent Epithelial Ovarian Cancer, Using Real-World Data From The ESME Database

一项回顾性多中心研究,旨在评估无铂间隔对复发性上皮性卵巢癌患者无进展生存期和总生存期的影响,使用来自ESME数据库的真实世界数据。

2025-02-010
PRE
Surgical Outcomes In Low-Grade Serous Ovarian Cancer: Comparing Primary Debulking Surgery With Neoadjuvant Chemotherapy

低级别浆液性卵巢癌的手术结果:比较初始肿瘤细胞减灭术与术前新辅助化疗

2025-02-010
PRE
Initial management and long-term outcome of advanced low-grade serous ovarian cancer (LGSOC) exploring role of surgery and maintenance therapy in the French multicentre ESME database
2023-10-011
OA
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
2019-07-0125
OAAI
Networking for ovarian rare tumors: a significant breakthrough improving disease management

卵巢罕见肿瘤的网络: 改善疾病管理的重大突破

2017-06-0124
OAAI